Richard Chesworth

KYMR

CHIEF SCIENTIFIC OFFICER · KYMERA THERAPEUTICS, INC. · CIK 0001821188

FILING MIX · LIFETIME36%/64%

BUYS

SELLS

TOTAL VALUE

$6.51M

COMPANIES

ACTIVE SINCE

Aug 2020

HOLDINGS NOW

AVG SELL PX

$54.13

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

5 backtested trades · 8 horizons

Forward-return performance of every backtestable P/S trade by Richard Chesworth, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.

HORIZON	TRADES	WIN RATE	INSIDER RETURN	SPY RETURN	MEAN EXCESS	MEDIAN EXCESS	T-STAT
7d	5	+20.00%	+4.16%	+0.83%	+3.33%	+4.41%	—
14d	5	+0.00%	+17.45%	+1.14%	+16.30%	+17.46%	—
30d	5	+0.00%	+20.66%	+0.29%	+20.38%	+23.74%	—
60d	5	+20.00%	+6.51%	+0.91%	+5.60%	+8.95%	—
90d	5	+20.00%	+12.71%	+5.41%	+7.30%	+11.94%	—
180d	5	+100.00%	-26.46%	-1.50%	-24.96%	-22.53%	—
1y	5	+100.00%	-45.58%	-3.78%	-41.80%	-42.30%	—
2y	5	+100.00%	-64.45%	+1.30%	-65.75%	-65.00%	—

How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.

Holdings over time

KYMR · 0 shares · as of Aug 27, 2021

Trading cadence · quarterly flow

BUY ● SELL ●

2020

2021

FLOW · 4 buys / 7 sellsCOVERAGE · 5 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED
KYMR KYMERA THERAPEUTICS, INC.	SALE Chief Scientific Officer	33,779	—	—	263,340	Aug 27, 2021	Aug 27, 2021 ↗
KYMR KYMERA THERAPEUTICS, INC.	PURCHASE Chief Scientific Officer	33,779	$20.00	$675.6K	33,779	Aug 27, 2021	Aug 27, 2021 ↗
KYMR KYMERA THERAPEUTICS, INC.	SALE Chief Scientific Officer	33,779	$60.12	$2.03M	0	Aug 27, 2021	Aug 27, 2021 ↗
KYMR KYMERA THERAPEUTICS, INC.	SALE Chief Scientific Officer	8,809	$49.90	$439.6K	45,191	Aug 17, 2021	Aug 19, 2021 ↗
KYMR KYMERA THERAPEUTICS, INC.	PURCHASE Chief Scientific Officer	54,000	$20.00	$1.08M	54,000	Aug 17, 2021	Aug 19, 2021 ↗
KYMR KYMERA THERAPEUTICS, INC.	SALE Chief Scientific Officer	288	$52.09	$15.0K	0	Aug 17, 2021	Aug 19, 2021 ↗
KYMR KYMERA THERAPEUTICS, INC.	SALE Chief Scientific Officer	54,000	—	—	297,119	Aug 17, 2021	Aug 19, 2021 ↗
KYMR KYMERA THERAPEUTICS, INC.	SALE Chief Scientific Officer	2,928	$51.68	$151.3K	288	Aug 17, 2021	Aug 19, 2021 ↗
KYMR KYMERA THERAPEUTICS, INC.	SALE Chief Scientific Officer	41,975	$50.37	$2.11M	3,216	Aug 17, 2021	Aug 19, 2021 ↗
KYMR KYMERA THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	60,000	—	—	60,000	Mar 1, 2021	Mar 3, 2021 ↗
KYMR KYMERA THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	351,119	—	—	351,119	Aug 20, 2020	Aug 21, 2020 ↗

Other insiders · KYMR

Loading peer insiders…

About this filer

CIK 0001821188

ROLE

Chief Scientific Officer

PRIMARY

KYMR

COMPANIES

ACTIVE SINCE

Aug 2020

MARKETPEEL · /INSIDER/0001821188DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

Richard Chesworth

The morning brief, before the bell.